Consumer-Enabled Research, the second goal of pioneering personalized genetics company 23andMe, reached its first generation with the launch of 23andWe. From BusinessWire: “23andWe marks a new approach to genetics research. By directly involving 23andMe customers in the company’s research projects, the goal is to conduct large-scale studies powered by a web-based community of diverse individuals… Continue reading 23andWe follows 23andMe: First generation of Consumer-Enabled Research
from my mailbox: Science-Business eXchange aka SciBX is a new publication from the makers of Nature and BioCentury that aims to improve the translation of today’s science into tomorrow’s products for the diagnosis, treatment and prevention of disease.
The O’Reilly AlphaTech Ventures Startup Camp is a nice option for the emerging personalized genomics companies or any web-related biotech startups to communicate and cooperate with alpha geeks and early technology adopters. Tim O’Reilly writes: The Thursday and Friday (July 10-11) before this year’s Foo Camp in Sebastopol July 11-13, O’Reilly AlphaTech Ventures will be… Continue reading O’Reilly Startup Camp for geeky biotech startups too!
Wow, I guess it’s time for me to move into the stock market business! Here’s the story via David Bradley’s tweet: Julie Kent, Search Engine Journal, April 21st, 2008: Google Wants to Index Genetic Information, Invests in Second DNA Start-Up In 2007, Google made headlines when they invested $4.4 million in 23andMe, a genetic screening… Continue reading How to predict the future via Twitter: Google invests in Navigenics
1. A start-up is a company with a limited operating history (Wikipedia). 2. Startup search “tracks the web technology ecosystem commonly referenced as “Web 2.0.” We collect facts and figures about new web products, startup companies, key startup employees, and the funding dollars powering their growth.” 3. 23andMe is a pioneering web-based, personalized genomics startup… Continue reading Dear StartupSearch: Is 23andMe a web-based startup or not?
Press release: “We at Life Extension Foundation are pleased to help finance BioTime‘s entry into the field of regenerative medicine. We believe that one of the most important applications of embryonic stem cell technology is the slowing and reversing of aging and age-related disease.